ReviewInternational journal of molecular sciences2022

MDM2-Based Proteolysis-Targeting Chimeras (PROTACs): An Innovative Drug Strategy for Cancer Treatment.

André T S Vicente et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.